AD4 is an artemisinin derivative that is a proteolytic targeting chimera (PROTAC) targeting PCLAF. AD4 can effectively degrade PCLAF in RS4,11 cells (IC50: 0.6 nM), thereby activating the p21/Rb axis and exerting anti-tumor activity. AD4 also prolonged survival of RS4,11-transplanted NOD/SCID mice, with in vivo efficacy[1].
Molecular Weight:
1035.23
Purity:
98.01
CAS Number:
[2918262-09-4]
Formula:
C55H78N4O15
Target:
PROTACs
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted